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Pancreatic β cells are responsible for maintaining glucose
homeostasis; their absence or malfunction results in dia-
betes mellitus. Although there is evidence that long
noncoding RNAs (lncRNAs) play important roles in devel-
opment and disease, none have been investigated in vivo
in the context of pancreas development. In this study,
we demonstrate that βlinc1 (β-cell long intergenic non-
coding RNA 1), a conserved lncRNA, is necessary for
the specification and function of insulin-producing β cells
through the coordinated regulation of a number of islet-
specific transcription factors located in the genomic vicin-
ity of βlinc1. Furthermore, deletion of βlinc1 results in de-
fective islet development and disruption of glucose
homeostasis in adult mice.
Supplemental material is available for this article.
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Type 2 diabetes (T2D) arises when pancreatic islets are no
longer able to compensate for the increasing demand of
insulin to maintain glucose homeostatic conditions. De-
spite the improvement in current therapies, >300 million
people live with T2D, and those numbers are expected to
almost double in the next 20 years. Accordingly, it is nec-
essary to increase our understanding of the underlying
biology of islet dysfunctions associated with T2D and
identify novel druggable targets.
Studies in pancreas development have identified nu-
merous transcription factors and lineage-specific regula-
tory networks that are required for the specification of
the different pancreatic cell types, including acini, ducts,
and endocrine cells (Arda et al. 2013). This functionally
diverse group of cells arises from a common pool of pan-
creatic progenitors in two major waves of differentiation
termed the primary and secondary transitions. Differenti-
ation of the pancreatic β cells occurs during the secondary
transition, and the signaling pathways and regulatory fac-
tors involved in this important developmental process
have been well characterized (for review, see Pan and
Wright 2011). These studies have provided the platform
to generate functional β cells in vitro for regenerativemed-
icine and suggested novel therapeutic approaches to pre-
vent and treat β-cell dysfunction.
The study of β-cell biology has been recently comple-
mented by genome-wide transcriptome analysis and char-
acterization of epigenetic modifications, suggesting that
non-protein-coding regions of the genome are integral to
the transcriptional network regulating development and
function of β cells (for review, see Arnes and Sussel
2015). Furthermore, a large number of T2D-associated
common variants that were identified in genome-wide as-
sociation studies map to noncoding genomic regions (Pas-
quali et al. 2014). Although there is increasing evidence
that long noncoding RNAs (lncRNAs) play an important
role in development and disease (Batista and Chang
2013), none have been investigated in vivo in the context
of pancreas development and β-cell function. In this study,
we describe the functional characterization of a newly
identified conserved lncRNA termed βlinc1 (β-cell long
intergenic noncoding RNA 1). We demonstrated that
βlinc1 is required for the proper specification and function
of endocrine cells through the coordinated regulation of a
number of islet-specific transcription factors located in
the genomic vicinity of βlinc1. Furthermore, deletion of
βlinc1 results in defective islet development and disrupt-
ed glucose homeostasis in the adult. These results have
important implications for the identification of novel reg-
ulatory mechanisms underlying T2D susceptibility and
suggest that ncRNAs could represent novel therapeutic
targets for the treatment of diabetes.
Results and Discussion
Characterization of βLINC1
lncRNAs expressed in the pancreatic islet are often highly
tissue-specific, associated with clusters of open chroma-
tin, and located in the genomic vicinity of transcription
factors involved in β-cell development and/or function
(Ku et al. 2012; Moran et al. 2012). We analyzed βLINC1
(formally HI-LNC15), a 6.8-kb post-transcriptionally pro-
cessed human islet-specific transcript without coding po-
tential (Moran et al. 2012) that is located in a region of
open chromatin ∼20 kb upstream ofNKX2.2, an essential
islet homeobox transcription factor gene (Supplemental
Fig. 1; Sussel et al. 1998). βLINC1 resides in a large syn-
tenic block located on chromosome 20 in humans and
chromosome 2 in mice (Fig. 1A). It is conserved in mam-
mals, with the largest stretches of homology located at
the putative promoter region, similar to many character-
ized lncRNAs (Carninci et al. 2005). This high level of
conservation enabled us to identify an orthologous βlinc1
transcript in mice (Fig. 1B). Mouse βlinc1 is also predicted
to have no coding potential (CPC score −0.261; CPAT
0.055) (Supplemental Fig. 2a), and comparative sequence
analysis between themouse and human βlinc1 transcripts
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did not reveal any conserved small ORFs. In mouse islets,
the genomic locus surrounding βlinc1 is enriched in
H3K4me1/3 and H3K27ac marks (Supplemental Fig. 2b),
and there is evidence for NeuroD1, Pdx1, and Foxa2 bind-
ing at the putative βlinc1 promoter region (Khoo et al.
2012; Jia et al. 2015). Despite these features, this 4.2-kb re-
gion of DNA within the βlinc1 locus did not confer en-
hancer activity in luciferase reporter assays in MIN6
cells (Supplemental Fig. 3).
Expression studies revealed that βlinc1 is enriched in
embryonic pancreata and adult islets (Fig. 1C). RNA in
situ analysis confirmed that βlinc1 expression is restricted
to adult islets and the trunk region of the developing pan-
creas (Fig. 1D). Furthermore, assessment of βlinc1 expres-
sion in several islet cell lines demonstrated that βlinc1 is
enriched in insulin-producing cells (Supplemental Fig. 4a),
corresponding to its expression in FACS-purified human
β cells (Supplemental Fig. 1).
βlinc1 RNA is retained in the nuclear fraction of β cells,
further suggesting a role for βlinc1 in transcriptional regu-
lation (Fig. 1E). Although βlinc1 is expressed at relatively
low levels, the half-life of the βlinc1 transcript is equiva-
lent to that of Tbp (Supplemental Fig. 4b,c). This suggests
that low transcript levels are not due to the degradation of
aberrant transcripts, similar to what has been document-
ed for other low-expressing lncRNAs (Clark et al. 2012).
Although there are limited tools available to predict the
function of lncRNAs based on nucleotide sequence or ge-
nomic location, there is growing evidence that a subset of
nuclear lncRNAs functions locally to regulate neighbor-
ing genes (Sauvageau et al. 2013; Vance et al. 2014). Con-
sistently, siRNA-mediated knockdown of βlinc1 RNA in
MIN6 cells resulted in the down-regulation of the adja-
cent coding gene Nkx2.2 (Fig. 1F), suggesting that the
βlinc1 transcript positively regulates the expression of
Nkx2.2.
βlinc1 knockout mice are glucose-intolerant
To determine the in vivo function of βlinc1, we generated
βlinc1-null mice (Supplemental Fig. 5). βlinc1+/− and
βlinc1−/− mice were viable and fertile. Consistent with
the expression of βlinc1 being restricted to the developing
endocrine pancreas and adult islet, βlinc1−/− mice were
mildly glucose-intolerant compared with βlinc1+/− or
βlinc1+/+ littermate controls (Fig. 2A). Furthermore,
βlinc1−/−mice displayed abnormal fasting plasma insulin
levels and increased insulin secretion under low-glucose
conditions and failed to elevate circulating insulin in re-
sponse to glucose stimulation (Fig. 2B; Supplemental
Fig. 6a). Interestingly, βlinc1−/−mice were also mildly in-
sulin-resistant despite the absence of βlinc1 expression in
muscle and subcutaneous white adipose tissue (Supple-
mental Fig. 6b,c).We did not detect additional phenotypes
in βlinc1−/− mice, particularly in other tissues where
Nkx2.2 is expressed, such as the brain and intestine,
which is also consistent with the restricted expression
and function of the βlinc1 transcript to the endocrine
pancreas.
Endocrine development is affected in βlinc1−/− mice
Given the expression of βlinc1 in the embryonic pancreas,
it was possible that aberrant glucose homeostasis was
caused by defects in pancreas development. Perinatal
βlinc1−/− mice did not exhibit overt defects in pancreas
morphology but displayed a 50% reduction in β cells and
an increase in the number of somatostatin-expressing
cells (Supplemental Fig. 7a,b; data not shown). We did
not detect alterations in islet cell ratios in βlinc1+/− neo-
nates (data not shown). The changes in islet cell ratios in
the βlinc1−/− animals appeared to be initiated during de-
velopment at the secondary transition. At embryonic
day 15.5 (E15.5), the number of insulin-producing β cells
was already significantly reduced, and there was an ap-
proximately threefold increase in the number of somato-
statin-producing cells (Fig. 2C,D; Supplemental Fig. 7c).
There was also a smaller but significant reduction in the
number of glucagon- and ghrelin-producing cells (Supple-
mental Fig. 7d–g). Changes in the expression of the corre-
sponding hormone genes and β-cell-specific transcription
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Figure 1. βlinc1 is a conserved endocrine-specific lncRNA. (A)
βlinc1 is located in a large syntenic block on human chromosome
20 and mouse chromosome 2 (purple lines). The position and direc-
tion of βlinc1 and the nearest adjacent genes are indicated. (B) Snap-
shot depicting βlinc1 transcript structure generated by de novo
assembly of RNA sequencing (RNA-seq) data frommouse embryonic
day 14.5 (E14.5) pancreas and islet samples and 30-way Multiz Align-
ment and Conservation. The mouse βlinc1 locus spans 8 kb, located
in a gene desert betweenNkx2.2 and Pax1 on the long (q) arm of chro-
mosome 2 (chr2: 147,030,314–147,038,352, mm9), with a 73.6% se-
quence conservation with the human βLINC1 locus as determined
by LiftOver. (C ) βlinc1 RNA expression was determined by quantita-
tive RT–PCR (qRT–PCR) in a tissue panel isolated from E15.5 embry-
os and adult islets. (D) RNA in situ hybridization of βlinc1 in
pancreatic sections of E18.5 embryos and adult pancreata showing en-
richment of the βlinc1 transcript in the trunk endocrine compart-
ment and adult islets. White dotted lines depict the endocrine area
and islets. The image is representative of at least three experiments.
(E) Cellular fractionation of MIN6 cells showing that βlinc1 is highly
enriched in nuclear versus cytosolic fractions. Gapdh and Malat1
were included as negative and positive controls of nuclear transcript
retention, respectively. Samples without the addition of reverse tran-
scriptase (noRT) were included to control for genomic contamina-
tion. n = 4. (F ) βlinc1 and Nkx2.2 expression in MIN6 cells treated
with two different siRNAs against βlinc1. n = 4. Error bars represent
±SEM. (∗) P < 0.05, Student’s t-test.
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factors were consistent with the changes in cell numbers
(Fig. 3A,B). Interestingly, we did not observe up-regulation
of δ-cell markers, such asHhex andCrhr2, suggesting that
deletion of βlinc1 may not cause the formation of excess
bona fide δ cells. However, we also did not detect coex-
pression of SST with the other endocrine hormones (Sup-
plemental Fig. 8), indicating that the increased numbers of
SST-expressing cellsmay arise from precocious or de novo
differentiation of immature and/or noncanonical δ-cell
populations.
The altered changes in islet cell ratios in βlinc1−/− em-
bryos also did not appear to be caused by aberrant prolifer-
ation or apoptosis, since there were no detectable
differences in pHistone H3 or cleaved caspase 3 staining
between the mutant and wild-type embryos (data not
shown). In support of a role for βlinc1 in the proper speci-
fication of some endocrine cell lineages, Neurog3 is also
decreased (Fig. 3B). Importantly, there was no effect on ex-
pression of the exocrinemarker Ptf1a (Fig. 3B), confirming
the endocrine specificity of βlinc1 function.
βlinc1 deficiency affects the expression of several genes
related to endocrine cell differentiation and β-cell
function
To identify the pathways regulated by βlinc1, we per-
formed global transcriptome analysis on E15.5 βlinc1−/−
versus βlinc1+/+ pancreata (Gene Expression Omnibus
[GEO] accession no. GSE73711) (Supplemental Table 1).
Consistent with the changes in endocrine cell ratios,
these data indicated a general dysregulation of endocrine
system development in the absence of βlinc1 (Supplemen-
tal Fig. 9a,b). Notably, we did not detect changes in genes
coding for transcription factors involved in the specifica-
tion and maintenance of pancreas progenitors; however,
in the absence of βlinc1, a large number of genes involved
in the specification of endocrine progenitors and in the
maturation and function of β cells were dysregulated (Sup-
plemental Fig. 9c). This supports a role for βlinc1 in the
proper specification of endocrine progenitors during the
secondary transition of pancreas development, when the
majority of β-cell differentiation occurs.
Although we did not detect altered islet cell ratios or
glucose metabolism defects in the heterozygous βlinc1+/−
pancreata, (Fig. 2a; Supplemental Fig. 7), βlinc1+/− embry-
os had reduced βlinc1 transcript and displayed defects in
the expression of several islet transcription factors, in-
cludingNkx2.2, Pax6, andMafb (Fig. 3B). To identify addi-
tional gene expression changes that were not confounded
by a change in islet cell type ratios, we performed tran-
scriptome analysis on E15.5 βlinc1+/− pancreata. Striking-
ly, there were many genes dysregulated in pancreata
lacking one copy of βlinc1 (Fig. 4A; Supplemental Table
1). This analysis also revealed that, in addition to
Nkx2.2, Pax6, and Mafb, five of the top 10 most signifi-
cantly dysregulated genes in the βlinc1+/− mice were
also located within an ∼55-Mb region on chromosome 2
(Fig. 4B,C). qPCR analysis verified that these five down-
regulated genes on chromosome 2 were significantly de-
creased in both βlinc1+/− and βlinc1−/− pancreata (Fig. 4D).
Dysregulated genes in βlinc1+/− localize to the genomic
vicinity of βlinc1
To determine whether the genes regulated by βlinc1were
biased based on their genomic location, we positionally
mapped all genes that were significantly dysregulated
(P < 0.05) in βlinc1+/− pancreata versus the wild-type con-
trols. Remarkably, a disproportionate number of dysregu-
lated genes mapped to a discrete region of chromosome 2,
within 40 Mb of the βlinc1 locus. Importantly, this is
not due to an increased number of genes that are expressed
on chromosome 2 during pancreas development (Sup-
plemental Fig. 10a,b). Moreover, gene ontology analysis
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Figure 3. βlinc1 regulates the expression of endocrine-specific genes.
(A) qPCR analysis of hormones in E15.5 pancreata. General reduction
of hormone expression with the up-regulation of somatostatin. n≥ 5.
(B) qPCR analysis of βlinc1 and several transcription factors involved
in pancreas development in E15.5 pancreata. n≥ 5. Error bars repre-
sent ±SEM. (∗) P < 0.05 βlinc1−/− versus βlinc1+/+; (#) P < 0.05
βlinc1+/− versus βlinc1+/+, Student’s t-test.
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Figure 2. βlinc1 knockout mice are glucose-intolerant and have de-
fects in endocrine specification. (A) βlinc1−/− 16-wk-old mice are
mildly glucose-intolerant. (AUC) Area under the curve. (B) Plasma in-
sulin levels in 16-wk-old βlinc1−/−mice (green) (n = 10) and littermate
βlinc1+/+ controlmice (blue) (n = 7) at 0 and 30min after glucose injec-
tion. (C ) Immunofluorescence analysis of pancreas development at
E15.5 showing a reduction of β cells and an increase of somatostat-
in-producing δ cells in βlinc1−/− mice compared with βlinc1+/+ and
βlinc1+/− mice. There are no apparent morphological defects in the
exocrine compartment, which was visualized by immunostaining
against CPA1. Images are representative of n > 3 mice. Bar, 50 µm.
(D) Quantification of hormone-producing cells in E15.5 pancreata.
n = 4. Error bars represent ±SEM. (∗) P < 0.05 βlinc1−/− versus
βlinc1+/+; (#) P < 0.05 βlinc1−/− versus βlinc1+/−, Student’s t-test.
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showed that the dysregulated genes on chromosome 2 are
associated with endocrine development and islet mor-
phology. Ingenuity Pathway Analysis also indicated that
the predominant upstream regulators affected by loss of
one allele of βlinc1 are the known islet-specific transcrip-
tion factors Pdx1 and NeuroD1. These pancreas-related
categories are lost if the same analysis is performed with
all of the genes that are located in this region of chromo-
some 2 (Supplemental Fig. 10a,b).
The remarkable observation that many βlinc1-regulat-
ed genes were located on the same chromosome as βlinc1
prompted us to investigate whether the observed gene ex-
pression changeswere due to loss of βlinc1 transcript rath-
er than the deletion of a DNA enhancer element, similar
to what was observed with Nkx2.2 regulation (Fig. 1F).
Assessment of the expression of additional candidate
βlinc1target genes located on chromosome 2 in response
to siRNA-mediated knockdown of βlinc1 in MIN6 cells
revealed the up-regulation of Sst expression and down-reg-
ulation of Scg5 and Pax6, confirming the biological role of
the βlinc1 transcript in gene regulation (Fig. 4E). More-
over, shRNA-mediated knockdown of the orthologous
human βLINC1 transcript in the human insulin-produc-
ing EndoC-βH1 cell line also causes altered expression of
genes dysregulated in βlinc1−/−mice (I Akerman and J Fer-
rer, in prep.). Therefore, it appears that the βlinc1 tran-
script regulates the expression of a set of functionally
related genes that are important for the development
and/or function of β cells.
In this study, we describe the first in vivo characteriza-
tion of a conserved islet-specific lncRNA. Homozygous
deletion of βlinc1 in mice causes the down-regulation of
important islet transcription factors and impaired β-cell
specification during embryonic development. Further-
more, adult mice lacking βlinc1 are glucose-intolerant
and display defective insulin secretion. Although it is pos-
sible that a subset of the observed βlinc1−/− phenotypes
could be due to the deletion of a regulatory element with-
in the genomic locus, siRNA- and shRNA-mediated
knockdown experiments of the βlinc1RNA in mouse
MIN6 cells (Figs. 1F, 4E) and human EndoC-βH1 cells re-
capitulated some of the gene changes observed in vivo.
Furthermore, the βlinc1 genomic locus does not appear
to have enhancer activities in MIN6 cells (Supplemental
Fig. 3); however, limitations of these in vitro studies pre-
vented us from ascribing all of the βlinc1 phenotypes to
loss of the βlinc1 transcript. Interestingly, although we
demonstrated that the βlinc1 transcript regulates several
important islet transcription factors, only a subset of the
βlinc1−/− phenotypes could be attributed to reduction of
Nkx2.2, Pax6, and/or MafB expression (Supplemental
Table 2; Pan andWright 2011), suggesting that βlinc1 is in-
volved in novel lineage regulatory pathways.
Transcriptome analysis of pancreata lacking one copy of
βlinc1 also revealed the dysregulation of a set of function-
ally related β−cell genes located in discrete genomic re-
gions. It is particularly intriguing that βlinc1 specifically
regulates three essential islet transcription factors,
ChgB, and additional β-cell genes on chromosome 2.
Long-range interchromosomal and intrachromosomal
interactions through chromosomal looping and transcrip-
tion factories are known to be involved in the transcrip-
tional coregulation of functionally related genes in a cell
type-specificmanner (Schoenfelder et al. 2010; Papantonis
et al. 2012). For example, insulin expression and calcium
signaling have been shown to be coupled through a long-
range chromosomal interaction that spans >65 Mb (Xu
et al. 2014). lncRNAs have also been implicated in high-
er-order gene regulation through chromatin organization,
and there is evidence of lncRNAs being highly enriched at
transcription “factories” (Caudron-Herger et al. 2015).
Therefore, it is possible that βlinc1 coordinately regulates
β-cell gene expression through the structural organization
of the chromatin in β cells. Analysis of the known chroma-
tin features and topologically associated domains (TADs)
in and around βlinc1 failed to reveal any obvious domains
or features that could explain the regulation of the genes
on chromosome 2. HiC analyses suggested that βlinc1
may be located at the edge of a TAD (Supplemental Fig.
11; Shen et al. 2012); however, the presence of this domain
does not correlate with the observed in vivo gene expres-
sion changes. For example, the TAD data include all of
the genes located between Insm1 and Foxa2, but only
two of the 13 genes within this domain (Nkx2-2 and
Insm1) are down-regulated in βlinc1−/−mice.
Although we are just beginning to understand a role for
lncRNAs in the cell, many findings have suggested that
lncRNAs provide a layer of cell-specific gene regulation
that contributes to cellular diversity (Mattick 2001). It is
therefore intriguing that βlinc1 has such a limited expres-
sion domain, and the phenotype of the global βlinc1−/−
mice is primarily restricted to β-cell formation and func-
tion. Furthermore, our discovery of βlinc1 as a novel
islet-specific transcriptional regulator has important im-
plications for understanding β-cell biology and suggests
that ncRNAs could represent novel therapeutic targets
for the treatment of diabetes.
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Figure 4. βlinc1 predominantly regulates the expression of β-cell-en-
riched genes that map to the same chromosomal region as βlinc1. (A)
Pie chart showing the total numbers and relative percentages of up-
regulated and down-regulated genes (P < 0.05) in βlinc1+/− versus
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plemental Fig. 10a). (C ) Schematic representation of themouse karyo-
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chromosome 2 in βlinc1+/− compared with βlinc1+/+ mice. (D) qRT–
PCR validation of RNA-seq results for the genes located in chromo-
some 2. (∗) P < 0.05 versus βlinc1+/+; (#) P < 0.05 versus βlinc1+/−. (E)
Down-regulation of βlinc1 with two different siRNAs in MIN6 cells
recapitulates the increase in somatostatin expression and down-regu-
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Materials and methods
Generation of the βlinc1 knockout allele
The βlinc1 knockout allele was generated using the RecombinaseMediate
Cassette Exchange protocol as previously described (Arnes et al. 2012)
with some modifications. Short arms (≈500 base pairs) homologous to
the flanking region of βlinc1 and to a downstream region (2.9 kb) were gen-
erated by PCR and cloned into pLCA.71/2272 and pMCS-DTA. The BAC
clone (RP23-236P19) was modified in two consecutive recombineering
steps in SW106 cells: The βlinc1 sequence was replaced with the puΔtk-
EM7-kan cassette, and the DTA-Ampr cassette was inserted 2.9 kb down-
stream from βlinc1, resulting in the replacement of 1 kb of genomic DNA
(Supplemental Fig. 5b). Positive clones were validated by PCR and DNA
sequencing, and a correctly modified BAC was electroporated into mouse
embryonic stem cells at Columbia University (Herbert Irving Comprehen-
sive Cancer Center Transgenic Shared Resource). Potentially recombined
clones were screened by PCR with primers P1 and P2 (Supplemental Fig.
5d,e). Two positive clones were used to generate chimericmice that result-
ed in germline transmission.
Mice
All mice weremaintained on amixed C57BL6/129SV genetic background.
All animals were maintained according to Columbia University Institu-
tional Animal Care and Use Committee approval protocol AAAG3206.
Physiological assays
Glucose tolerance tests, measurement of plasma insulin, and insulin
secretion assays were performed as previously described (Gu et al. 2010).
Cell lines and transfection
MIN6, αTC1 clone 6 (American Type Culture Collection), and PG1 cells
(provided by Dr. Jeffrey Zigman, University of Texas Southwestern Medi-
cal Center) were passaged and maintained following standard techniques
in 5% CO2 and 95% air. MIN6 cells were transfected with 10 nM siRNA
targeting βlinc1 and a scrambled control (Silencer Select, Ambion) using
Lipofectamine 2000 following the manufacturer’s instructions (Life
Technologies). siRNAs targeting βlinc1were designed using the algorithm
provided by the manufacturer, and sequences are listed in Supplemental
Table 3.
Enhancer activity
A 4.2-kb fragment of the βlinc1 genomic locus (chr2: 147,030,443–
147,034,638, mm9) was cloned into the PGL4.27 luciferase vector. One
microgram of the experimental vector PGL4.27-βlinc1 region and the pos-
itive controls (CDKN2BAS enhancer, Ins2 promoter, and NeuroD promot-
er/enhancer) were individually cotransfectedwith 0.1 µg of pRL intoMIN6
cells in triplicate. Luciferase activity was measured after 48 h. PGL4.23-
CDKN2BAS was a gift from Jorge Ferrer (Addgene plasmid no. 60296).
PGL3-Ins2 and PGL3-NeuroD have been previously described (Raum
et al. 2006; Anderson et al. 2009). Luciferase values were normalized to
Renilla activity to account for transfection efficiencies and were expressed
as fold increase over the empty vector.
RNA in situ hybridization
The βlinc1 probe was generated by PCR from E15.5 pancreas cDNA and
cloned into pCRII-TOPO (Life Technologies). Sense and antisense probes
were labeled with the DIG RNA-labeling mix (Roche Applied Science).
RNA in situ hybridization was performed as previously described (Mas-
tracci et al. 2013), including a short treatment of proteinase K digestion.
Immunofluorescence
Tissue processing and immunofluorescence analysis were performed as
previously described (Arnes et al. 2012). Primary antibodies are listed in
Supplemental Table 3. DAPI (1:1000; Invitrogen) was applied for 30 min
following secondary antibody incubation: DyLight-488, DyLight-549,
DyLight-649, Alexa-488, and Alexa-647 (Jackson Immunoresearch). Imag-
es were acquired with either an epifluorescence (Leica DM5500) or a con-
focal (Zeiss LSM 710) microscope.
Morphometric analysis and cell counting
Morphometric analysis was performed in E15.5 and postnatal day 2 pan-
creata. The entire organ was sectioned, and at least six evenly distributed
sections were analyzed. The number of endocrine cells was determined
relative to the total pancreatic area. Pancreas areawas quantified using Im-
age Pro Plus 5.0.1 software (Media Cybernetics).
Cellular fractionation
MIN6 cells were grown to confluency, detached by trypsinization, and pel-
leted. Half of the pellet was used for total RNA isolation, and the other half
was used for nuclear and cytoplasmic isolation using the PARIS kit
(Ambion) following the manufacturer’s instructions.
RNA extraction and quantitative RT–PCR analysis
Total RNAwas isolated and analyzed as previously described (Arnes et al.
2012). Primers and probes are listed in Supplemental Table 3.
RNA sequencing (RNA-seq) analysis
Total RNA from βlinc1+/+, βlinc1+/−, and βlinc1−/− mice was converted
into cDNA libraries (TruSeq RNA sample preparation kit version 2, Illu-
mina) using poly-A pull-down for mRNA enrichment. Sequencing was
performed to a depth of 30 million pairs in three biological replicates per
condition. Differential expression between replicates was assessed using
DESeq (R package). All samples had RNA integrity (RIN) values >9.0 as de-
termined with Agilent Bioanalyzer 2100. Complete RNA-seq data are
available through GEO accession number GSE73711.
TADs
TADs in the genomic vicinity of βlinc1were identified from themouse en-
code project at the Ren laboratory (http://chromosome.sdsc.edu/mouse).
Statistics
All datawere expressed as mean ± SEM.Mean and SEM values were calcu-
lated from at least three biological replicates. The statistical significance
was measured by two-tailed Student’s t-test.
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